Results 211 to 220 of about 68,573 (295)

A clinical model for highly accurate prediction of blood glucose depression after continuous intravenous insulin therapy in hyperglycemic emergencies, a multicenter retrospective cohort study

open access: yesJournal of Diabetes Investigation, Volume 16, Issue 10, Page 1820-1828, October 2025.
This study developed a clinical model using a gradient boosting decision tree (GBDT) to predict blood glucose reduction (ΔGlu) after continuous intravenous insulin therapy in hyperglycemic emergencies. A multicenter retrospective cohort analysis identified key predictive factors, including initial blood glucose, bicarbonate concentration, insulin flow ...
Yuichiro Iwamoto   +18 more
wiley   +1 more source

Neutrophil Extracellular Traps Are Not Linked to Decompensation, ACLF, or Death in Clinically Stable Patients With ACLD

open access: yesLiver International, Volume 45, Issue 10, October 2025.
ABSTRACT Background and Aims Neutrophil extracellular traps (NETs) are part of the body's innate immune response. In animal models, NETs aggravated liver injury and promoted disease progression/portal hypertension by the formation of (micro)thrombi leading to parenchymal extinction.
Lorenz Balcar   +17 more
wiley   +1 more source

2025 ACVIM Forum Research Abstract Program

open access: yes
Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley   +1 more source

Impact of Underlying Portal Hypertension on Severity and Course of Acute‐On‐Chronic Liver Failure

open access: yesLiver International, Volume 45, Issue 10, October 2025.
ABSTRACT Background and Aims The impact of portal hypertension (PH) during acute‐on‐chronic liver failure (ACLF) remains unclear. This study investigated the link between underlying PH severity, systemic inflammation (SI), and the course of ACLF. Methods Consecutive patients with ACLF (n = 192) who met the EASL‐CLIF criteria were retrospectively ...
Vlad Taru   +11 more
wiley   +1 more source

Disseminated Intravascular Coagulation in a Patient with Systemic Lupus Erythematosus with Lupus Anticoagulant.

open access: bronze, 1993
Mitsuhiko Tanaka   +4 more
openalex   +2 more sources

Transforming treatment paradigms: Focus on personalized medicine for high‐grade serous ovarian cancer

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 5, Page 436-460, September/October 2025.
Abstract High‐grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of ovarian cancer, accounting for approximately 70% of all ovarian cancer cases and contributing significantly to the high mortality rates associated with this disease.
Pawel Kordowitzki   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy